Publications by authors named "Christopher C Nolan"

40Publications

The combined expression of solute carriers is associated with a poor prognosis in highly proliferative ER+ breast cancer.

Breast Cancer Res Treat 2019 May 22;175(1):27-38. Epub 2019 Jan 22.

Nottingham Breast Cancer Research Centre, Division of Cancer and Stem Cells, School of Medicine, Nottingham City Hospital, University of Nottingham, Hucknall Road, Nottingham, NG5 1PB, UK.

View Article and Find Full Text PDF
May 2019

Glutamate dehydrogenase (GLUD1) expression in breast cancer.

Breast Cancer Res Treat 2019 Feb 23;174(1):79-91. Epub 2018 Nov 23.

Nottingham Breast Cancer Research Centre, Division of Cancer and Stem Cells, School of Medicine, University of Nottingham, Hucknall Road, Nottingham, NG5 1PB, UK.

View Article and Find Full Text PDF
February 2019

Kinesin family member-18A (KIF18A) is a predictive biomarker of poor benefit from endocrine therapy in early ER+ breast cancer.

Breast Cancer Res Treat 2019 Jan 10;173(1):93-102. Epub 2018 Oct 10.

Nottingham Breast Cancer Research Centre, Division of Cancer and Stem Cells, School of Medicine, Nottingham City Hospital, University of Nottingham, Hucknall Road, Nottingham, NG5 1PB, UK.

View Article and Find Full Text PDF
January 2019

Saccharomyces cerevisiae-like 1 (SEC14L1) is a prognostic factor in breast cancer associated with lymphovascular invasion.

Mod Pathol 2018 11 28;31(11):1675-1682. Epub 2018 Jun 28.

Division of Cancer and Stem Cells, School of Medicine, University of Nottingham and Nottingham University Hospital NHS Trust, Nottingham City Hospital, Nottingham, UK.

View Article and Find Full Text PDF
November 2018

Thioredoxin-interacting protein is an independent risk stratifier for breast ductal carcinoma in situ.

Mod Pathol 2018 12 28;31(12):1807-1815. Epub 2018 Jun 28.

Academic Pathology, Division of Cancer and Stem Cells, School of Medicine, The University of Nottingham, Nottingham City Hospital, Nottingham, UK.

View Article and Find Full Text PDF
December 2018

Heterogeneity of tumour-infiltrating lymphocytes in breast cancer and its prognostic significance.

Histopathology 2018 Dec 9;73(6):887-896. Epub 2018 Oct 9.

Nottingham Breast Cancer Research Centre, Division of Cancer and Stem Cells, School of Medicine, University of Nottingham, Nottingham City Hospital, Nottingham, UK.

View Article and Find Full Text PDF
December 2018

Mediator complex (MED) 7: a biomarker associated with good prognosis in invasive breast cancer, especially ER+ luminal subtypes.

Br J Cancer 2018 04 28;118(8):1142-1151. Epub 2018 Mar 28.

Division of Cancer and Stem Cells, School of Medicine, University of Nottingham and Nottingham University Hospitals NHS Trust, City Hospital Campus, Nottingham, NG5 1PB, UK.

View Article and Find Full Text PDF
April 2018

The amino acid transporter SLC7A5 confers a poor prognosis in the highly proliferative breast cancer subtypes and is a key therapeutic target in luminal B tumours.

Breast Cancer Res 2018 03 22;20(1):21. Epub 2018 Mar 22.

Academic Pathology, Division of Cancer and Stem Cells, School of Medicine, University of Nottingham, Nottingham City Hospital, Hucknall Road, Nottingham, NG5 1PB, UK.

View Article and Find Full Text PDF
March 2018

The multifunctional solute carrier 3A2 (SLC3A2) confers a poor prognosis in the highly proliferative breast cancer subtypes.

Br J Cancer 2018 04 16;118(8):1115-1122. Epub 2018 Mar 16.

Academic Pathology, Division of Cancer and Stem Cells, School of Medicine, Nottingham City Hospital, University of Nottingham, Hucknall Road, Nottingham, NG5 1PB, UK.

View Article and Find Full Text PDF
April 2018

MYC regulation of glutamine-proline regulatory axis is key in luminal B breast cancer.

Br J Cancer 2018 01 23;118(2):258-265. Epub 2017 Nov 23.

Academic Pathology, Division of Cancer and Stem Cells, School of Medicine, University of Nottingham, Nottingham City Hospital, Hucknall Road, Nottingham NG5 1PB, UK.

View Article and Find Full Text PDF
January 2018

Phenotypic characterisation of breast cancer: the role of CDC42.

Breast Cancer Res Treat 2017 Jul 27;164(2):317-325. Epub 2017 Apr 27.

Division of Cancer and Stem Cells, School of Medicine, University of Nottingham and Nottingham University Hospitals NHS Trust, City Hospital Campus, Nottingham, NG5 1PB, UK.

View Article and Find Full Text PDF
July 2017

Prognostic significance of tumour infiltrating B lymphocytes in breast ductal carcinoma in situ.

Histopathology 2017 Aug 26;71(2):258-268. Epub 2017 May 26.

Division of Cancer and Stem Cells, School of Medicine, The University of Nottingham and Nottingham University Hospitals NHS Trust, Nottingham City Hospital, Nottingham, UK.

View Article and Find Full Text PDF
August 2017

Further evidence to support bimodality of oestrogen receptor expression in breast cancer.

Histopathology 2017 Feb 28;70(3):456-465. Epub 2016 Nov 28.

Division of Cancer and Stem Cells, School of Medicine, The University of Nottingham and Nottingham University Hospitals NHS Trust, Nottingham City Hospital, Nottingham, UK.

View Article and Find Full Text PDF
February 2017

Nottingham Prognostic Index Plus: Validation of a clinical decision making tool in breast cancer in an independent series.

J Pathol Clin Res 2016 Jan 15;2(1):32-40. Epub 2016 Jan 15.

Division of Cancer and Stem CellsBreast Cancer Pathology Research Group, School of Medicine, University of Nottingham, Nottingham City HospitalHucknall RoadNottinghamNG5 1PB; Cellular Pathology, Nottingham University Hospitals NHS TrustHucknall RoadNottinghamNG5 1PB.

View Article and Find Full Text PDF
January 2016

The prognostic significance of STAT3 in invasive breast cancer: analysis of protein and mRNA expressions in large cohorts.

Breast Cancer Res Treat 2016 Feb 23;156(1):9-20. Epub 2016 Feb 23.

Division of Cancer and Stem Cells, School of Medicine, University of Nottingham and Nottingham University Hospitals NHS Trust, City Hospital Campus, Nottingham, NG5 1PB, UK.

View Article and Find Full Text PDF
February 2016

Clinical utility of reverse phase protein array for molecular classification of breast cancer.

Breast Cancer Res Treat 2016 Jan 9;155(1):25-35. Epub 2015 Dec 9.

Department of Histopathology, Division of Cancer and Stem Cells, School of Medicine, The University of Nottingham, Nottingham, UK.

View Article and Find Full Text PDF
January 2016

DNA damage response markers are differentially expressed in BRCA-mutated breast cancers.

Breast Cancer Res Treat 2015 Feb 19;150(1):81-90. Epub 2015 Feb 19.

Division of Cancer and Stem Cells, School of Medicine, University of Nottingham, Nottingham, UK,

View Article and Find Full Text PDF
February 2015

Biological and clinical significance of PARP1 protein expression in breast cancer.

Breast Cancer Res Treat 2015 Jan 21;149(2):353-62. Epub 2014 Dec 21.

Division of Cancer and Stem Cells, School of Medicine, Nottingham City Hospital, University of Nottingham, Hucknall Road, Nottingham, NG5 1PB, UK,

View Article and Find Full Text PDF
January 2015

Epithelial mesenchymal transition in early invasive breast cancer: an immunohistochemical and reverse phase protein array study.

Breast Cancer Res Treat 2014 Jun 26;145(2):339-48. Epub 2014 Apr 26.

Department of Histopathology, University of Nottingham and Nottingham University Hospitals NHS Trust, Nottingham, UK,

View Article and Find Full Text PDF
June 2014

HER2/HER3 heterodimers and p21 expression are capable of predicting adjuvant trastuzumab response in HER2+ breast cancer.

Breast Cancer Res Treat 2014 May 6;145(1):33-44. Epub 2014 Apr 6.

Molecular Pathology Research Unit, Division of Cancer and Stem Cells, School of Medicine, University of Nottingham, Nottingham City Hospital, Nottingham, NG5 1PB, UK,

View Article and Find Full Text PDF
May 2014

Characterisation of HER heterodimers in breast cancer using in situ proximity ligation assay.

Breast Cancer Res Treat 2014 Apr 21;144(2):273-85. Epub 2014 Feb 21.

Molecular Pathology Research Unit, Division of Oncology, School of Medicine, Nottingham City Hospital, University of Nottingham, Nottingham, NG5 1PB, UK.

View Article and Find Full Text PDF
April 2014

SHON is a novel estrogen-regulated oncogene in mammary carcinoma that predicts patient response to endocrine therapy.

Cancer Res 2013 Dec;73(23):6951-62

Authors' Affiliations: Liggins Institute, University of Auckland, Auckland, New Zealand; Department of Clinical Oncology; Department of Histopathology, School of Molecular Medical Sciences, University of Nottingham and Nottingham University Hospitals NHS Trust, Nottingham, United Kingdom; The Key Laboratory of Molecular Epigenetics of Ministry of Education, Northeast Normal University; The Institute of Genetics and Cytology, Northeast Normal University, Changchun; Institute of Genetics and Developmental Biology, Chinese Academy of Sciences, Beijing; Hefei National Laboratory for Physical Sciences at Microscale and School of Life Sciences, University of Science and Technology of China; Department of Pathology, Anhui Medical University, Hefei, China; Cancer Science Institute of Singapore, and Department of Pharmacology, National University of Singapore; and National Cancer Institute of Singapore, National University Health System, Singapore.

View Article and Find Full Text PDF
December 2013

A quantifier-based fuzzy classification system for breast cancer patients.

Artif Intell Med 2013 Jul 18;58(3):175-84. Epub 2013 Jun 18.

School of Computer Science, Advanced Data Analysis Centre, University of Nottingham, Jubilee Campus, Wollaton Road, Nottingham NG8 1BB, UK.

View Article and Find Full Text PDF
July 2013

Poly(adenosine diphosphate-ribose) polymerase expression in BRCA-proficient ovarian high-grade serous carcinoma; association with patient survival.

Hum Pathol 2013 Aug 8;44(8):1638-47. Epub 2013 Apr 8.

Department of Histopathology, Nottingham University Hospitals NHS Trust, Queen's Medical Centre Campus, Nottingham, NG7 2UH, UK.

View Article and Find Full Text PDF
August 2013

The microRNA maturation regulator Drosha is an independent predictor of outcome in breast cancer patients.

Breast Cancer Res Treat 2013 Jan 6;137(1):139-53. Epub 2012 Dec 6.

Department of Histopathology, School of Molecular Medical Sciences, University of Nottingham, Nottingham, UK.

View Article and Find Full Text PDF
January 2013

TOMM34 expression in early invasive breast cancer: a biomarker associated with poor outcome.

Breast Cancer Res Treat 2012 Nov 4;136(2):419-27. Epub 2012 Oct 4.

Division of Pathology, School of Molecular Medical Sciences, University of Nottingham, Nottingham, United Kingdom.

View Article and Find Full Text PDF
November 2012

Loss of Dicer expression is associated with breast cancer progression and recurrence.

Breast Cancer Res Treat 2012 Sep 21;135(2):403-13. Epub 2012 Jul 21.

Department of Histopathology, School of Molecular Medical Sciences, University of Nottingham and Nottingham University Hospitals NHS Trust, Nottingham NG7 2UH, UK.

View Article and Find Full Text PDF
September 2012

Fatty acid binding protein 7 expression and its sub-cellular localization in breast cancer.

Breast Cancer Res Treat 2012 Jul 6;134(2):519-29. Epub 2012 May 6.

Department of Histopathology and School of Molecular Medical Sciences, The University of Nottingham and Nottingham University Hospitals NHS Trust, Nottingham City Hospital, Nottingham, UK.

View Article and Find Full Text PDF
July 2012

Pathological outcomes in kidney and brain in male Fischer rats given dietary ochratoxin A, commencing at one year of age.

Toxins (Basel) 2010 05 13;2(5):1100-10. Epub 2010 May 13.

Centre for Environmental Policy, Imperial College London, London, SW7 2AZ, UK.

View Article and Find Full Text PDF
May 2010

Reversible disruption of tight junction complexes in the rat blood-brain barrier, following transitory focal astrocyte loss.

Glia 2004 Oct;48(1):1-13

MRC Applied Neuroscience Group, School of Biomedical Sciences, Queen's Medical Centre, University of Nottingham, NG7 2UH, Nottingham, United Kingdom.

View Article and Find Full Text PDF
October 2004